The ceremony took place in Berlin on March 15, where Fabian Theis was one of the ten awardees for his groundbreaking work in bioinformatics and systems biology. This year, the Leibniz prize was awarded with €2.5 million.
Fabian Theis about his new award: “I am super excited and grateful about this recognition! The past years have seen a rapid explosion of single cell genomics. The produced big data makes this a fantastic area to explore with machine and deep learning techniques to understand cellular decisions in health and disease. What also stands out is the immensely collaborative research - with teams truly spanning the globe. The future of medicine is data-based, and I hope to contribute to the foundations of a transformative biomedical era. I am delighted to receive DFG’s support with the prestigious Leibniz Prize, and I am deeply grateful to my fantastic team, my department, Helmholtz Munich and Helmholtz AI, the Helmholtz Association, the Technical University of Munich and in particular my family, without whom all of this would not have been possible.”
Helmholtz Munich CEO Matthias Tschöp adds: “With his visionary research in the field of artificial intelligence in biomedicine, Fabian Theis leads one of our strategically most important topics at the center and within the entire Helmholtz Association. Due to his scientific excellence, his numerous transformative discoveries and his extraordinary research personality, Fabian Theis occupies a leading position worldwide in his field. I cannot imagine a worthier winner of the Leibniz Prize 2023.”